Literature DB >> 17572271

Oral anti-hyperglycemic agents for the management of gestational diabetes mellitus.

Oded Langer1.   

Abstract

The purpose of this review is to provide a brief overview for understanding the management guidelines of gestational diabetes. The rationale for the use of oral antidiabetic drugs is provided based on validation by appropriately conducted research trials. Concerns over teratogenicity due to possible placental transfer, neonatal and maternal outcome, and basic pharmacologic benefits are addressed.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17572271     DOI： 10.1016/j.ogc.2007.03.004

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN： 0889-8545            Impact factor:   2.844


  4 in total

1.  Do immigrants from Turkey, Pakistan and Ex-Yugoslavia with newly diagnosed type 2 diabetes initiate recommended statin therapy to the same extent as Danish-born residents? A nationwide register study.

Authors:  Diana C Sanchez-Ramirez; Allan Krasnik; Helle Wallach Kildemoes
Journal:  Eur J Clin Pharmacol       Date:  2012-05-31       Impact factor: 2.953

Review 2.  Oral Hypoglycemic Agents in pregnancy: An Update.

Authors:  Nagandla Kavitha; Somsubhra De; Sachchithanantham Kanagasabai
Journal:  J Obstet Gynaecol India       Date:  2013-03-27

Review 3.  Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews.

Authors:  Ruth Martis; Caroline A Crowther; Emily Shepherd; Jane Alsweiler; Michelle R Downie; Julie Brown
Journal:  Cochrane Database Syst Rev       Date:  2018-08-14

4.  A comparison of the anti-diabetic potential of d-ribose-l-cysteine with insulin, and oral hypoglycaemic agents on pregnant rats.

Authors:  Abraham A A Osinubi; Leke Jacob Medubi; Edidiong N Akang; Lawal K Sodiq; Titilola A Samuel; Taiwo Kusemiju; James Osolu; Danladi Madu; Olufemi Fasanmade
Journal:  Toxicol Rep       Date:  2018-08-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.